Ionescu D, Mitre C, Leuke L, Bertianu C, Paskarenko G, Puia C, Bertianu M
Anesteziol Reanimatol. 2007 Mar-Apr(2):50-2.
This randomized double-blind study was undertaken to evaluate the efficacy of ondasetron and dexamathesone in reducing the incidence of postoperative nausea and vomiting after laparoscopic cholecystectomy. The study covered 60 patients (ASA I/II) who had undergone laparoscopic cholecystectomy under general anesthesia. The patients were divided into two groups: 1) 30 patients who received dexamethasone, 4 mg i.v.; and 2) 30 patients who took ondansetron, 4 mg i.v., prior to general anesthesia. Postoperatively, nausea, vomiting, and severe pain (VAS) were observed every 6 hours within the first 24 hours. Postoperative nausea and vomiting occurred in 6 (20) patients in Group I and in 13 (43.33) patients in Group 2 (p < 0.05), while vomiting did only in 5 (16.66%) patients in Group I and 4 (13.33%) in Group 2 (p > 0.05). The least intensity of postoperative pain was observed in Group 1, but the difference between the study groups was insignificant. It is concluded that dexamethasone is more effective in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy than ondansetron. This is mainly determined by a significant reduction in the incidence of postoperative nausea.
本随机双盲研究旨在评估昂丹司琼和地塞米松在降低腹腔镜胆囊切除术后恶心呕吐发生率方面的疗效。该研究纳入了60例(ASA I/II级)在全身麻醉下接受腹腔镜胆囊切除术的患者。患者被分为两组:1)30例接受静脉注射4 mg地塞米松的患者;2)30例在全身麻醉前静脉注射4 mg昂丹司琼的患者。术后,在最初24小时内每6小时观察一次恶心、呕吐和重度疼痛(视觉模拟评分法)情况。第一组有6例(20%)患者发生术后恶心呕吐,第二组有13例(43.33%)患者发生术后恶心呕吐(p<0.05),而第一组仅有5例(16.66%)患者发生呕吐,第二组有4例(13.33%)患者发生呕吐(p>0.05)。第一组观察到的术后疼痛强度最低,但研究组之间的差异不显著。得出的结论是,在预防腹腔镜胆囊切除术后恶心呕吐方面,地塞米松比昂丹司琼更有效。这主要是由术后恶心发生率的显著降低所决定的。